FDA Inspection 1032524 — Kamran Khan, MD
The FDA completed an inspection of Kamran Khan, MD on Nov 7, 2017 in Baytown, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 7, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baytown, TX (United States)
Additional Details
Clinical Investigator (CI)